Published in Diabetes Care on July 01, 2010
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm (2012) 0.89
Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy. Biomed Res Int (2015) 0.88
Proteomic analyses of the vitreous humour. Mediators Inflamm (2012) 0.87
Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema. Diabetes Care (2013) 0.77
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18
Ghostwriting policies in high-impact biomedical journals: a cross-sectional study. JAMA Intern Med (2013) 2.61
Misconduct policies in high-impact biomedical journals. PLoS One (2012) 2.29
Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS One (2009) 2.03
Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care (2006) 1.99
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev (2006) 1.92
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal (2011) 1.90
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care (2006) 1.80
Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens. J Antimicrob Chemother (2011) 1.60
APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis (2009) 1.56
Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care (2004) 1.55
The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol (2010) 1.52
[Factors influencing CRP levels in the diabetic population]. Med Clin (Barc) (2005) 1.47
Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst (2013) 1.47
Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab (2009) 1.46
Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Am J Gastroenterol (2007) 1.44
Vibrio parahaemolyticus in shellfish and clinical samples during two large epidemics of diarrhoea in southern Chile. Environ Microbiol (2006) 1.42
[Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life]. Med Clin (Barc) (2003) 1.40
Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res (2008) 1.33
High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care (2004) 1.32
Fenofibrate - a potential systemic treatment for diabetic retinopathy? Am J Ophthalmol (2012) 1.31
Epidemiology of Vibrio parahaemolyticus outbreaks, southern Chile. Emerg Infect Dis (2009) 1.29
Apolipoprotein A1 is overexpressed in the retina of diabetic patients. Am J Ophthalmol (2008) 1.23
Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) (2006) 1.23
Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol (2006) 1.21
Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2012) 1.20
Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care (2007) 1.20
The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol Chem (2009) 1.15
Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care (2006) 1.14
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation (2013) 1.13
Dynamics of clinical and environmental Vibrio parahaemolyticus strains during seafood-related summer diarrhea outbreaks in southern Chile. Appl Environ Microbiol (2009) 1.12
Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes (2010) 1.08
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. Arch Ophthalmol (2008) 1.07
Advances in the medical treatment of diabetic retinopathy. Diabetes Care (2009) 1.06
Vibrio parahaemolyticus strains isolated during investigation of the summer 2006 seafood related diarrhea outbreaks in two regions of Chile. Int J Food Microbiol (2007) 1.04
Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care (2008) 1.02
Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol (2002) 1.02
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc (2013) 1.00
Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology (2011) 1.00
Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol Vis (2008) 1.00
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol (2012) 1.00
Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care (2006) 0.99
Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J Cell Physiol (2012) 0.99
Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One (2011) 0.98
Financial, nonfinancial and editors' conflicts of interest in high-impact biomedical journals. Eur J Clin Invest (2013) 0.98
Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy. Mol Vis (2013) 0.97
CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol (2004) 0.96
A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol (2012) 0.96
Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care (2012) 0.96
Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis (2009) 0.95
Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics (2006) 0.94
Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Investig Drugs (2007) 0.94
Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability. Invest Ophthalmol Vis Sci (2011) 0.93
Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. Invest Ophthalmol Vis Sci (2010) 0.92
[Treatment of diabetes mellitus: general goals, and clinical practice management]. Rev Esp Cardiol (2002) 0.92
Neuroprotection in diabetic retinopathy. Curr Diab Rep (2012) 0.92
Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence. Cancer Res (2013) 0.91
Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis. Am J Kidney Dis (2009) 0.91
The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401). Arthritis Rheum (2008) 0.91
Proteomic analysis of electronegative low-density lipoprotein. J Lipid Res (2010) 0.90
The protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells. FASEB J (2012) 0.90
Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. J Proteomics (2013) 0.90
Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm (2012) 0.89
Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PLoS One (2009) 0.89
Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects. Diabetes Care (2005) 0.88
Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine (2011) 0.88
Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema. Diabetes Care (2007) 0.88